| Housam Soukieh, MD | |
|
1513 Union Ave, Suite 1600, Moberly, MO 65270-9402 | |
| (660) 263-2400 | |
| (660) 263-5610 |
| Full Name | Housam Soukieh |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 1513 Union Ave, Moberly, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568422673 | NPI | - | NPPES |
| 036101288 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 036-101288 (Illinois) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 2014021757 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Mary's Hospital Jefferson City | Jefferson city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Regional Health Services | 8921917352 | 55 |
News Archive
A new Reuters/Ipsos poll shows that though most Americans continue to oppose the health law, they support many of its provisions. Meanwhile, news outlets continue to report on what the impact would be - both in terms of people and the markets - if the law is overturned and these provisions are rolled back.
Low socioeconomic status is linked to significant reductions in life expectancy and should be considered a major risk factor for ill health and early death in national and global health policies, according to a study of 1.7 million people published by The Lancet.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it will present pre-clinical data on its anticancer compound RX-8243 at the American Association for Cancer Research (AACR) 101st Annual Meeting, held in Washington, D.C., April 17-21, 2010, at the Walter E. Washington Convention Center.
CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO".
› Verified 4 days ago
| Entity Name | Ssm Regional Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649217837 PECOS PAC ID: 8921917352 Enrollment ID: O20070213000635 |
News Archive
A new Reuters/Ipsos poll shows that though most Americans continue to oppose the health law, they support many of its provisions. Meanwhile, news outlets continue to report on what the impact would be - both in terms of people and the markets - if the law is overturned and these provisions are rolled back.
Low socioeconomic status is linked to significant reductions in life expectancy and should be considered a major risk factor for ill health and early death in national and global health policies, according to a study of 1.7 million people published by The Lancet.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it will present pre-clinical data on its anticancer compound RX-8243 at the American Association for Cancer Research (AACR) 101st Annual Meeting, held in Washington, D.C., April 17-21, 2010, at the Walter E. Washington Convention Center.
CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO".
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Housam Soukieh, MD 1513 Union Ave, Suite 1600, Moberly, MO 65270-9402 Ph: (660) 263-2400 | Housam Soukieh, MD 1513 Union Ave, Suite 1600, Moberly, MO 65270-9402 Ph: (660) 263-2400 |
News Archive
A new Reuters/Ipsos poll shows that though most Americans continue to oppose the health law, they support many of its provisions. Meanwhile, news outlets continue to report on what the impact would be - both in terms of people and the markets - if the law is overturned and these provisions are rolled back.
Low socioeconomic status is linked to significant reductions in life expectancy and should be considered a major risk factor for ill health and early death in national and global health policies, according to a study of 1.7 million people published by The Lancet.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it will present pre-clinical data on its anticancer compound RX-8243 at the American Association for Cancer Research (AACR) 101st Annual Meeting, held in Washington, D.C., April 17-21, 2010, at the Walter E. Washington Convention Center.
CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO".
› Verified 4 days ago
Jessica Winn, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1513 Union Ave Ste 1500, Moberly, MO 65270 Phone: 660-263-0524 Fax: 660-263-0524 | |
Dr. Catherine M Monti, MD, MPH Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1517 Union Ave, Suite D, Moberly, MO 65270 Phone: 660-263-1400 Fax: 660-263-1535 | |
Dr. Ameena Anees, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1513 Union Ave, Ste 1600, Moberly, MO 65270 Phone: 660-263-2400 Fax: 660-263-5610 | |
Dr. Sanjeev Dhari Ravipudi, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2103 Silva Ln, Moberly, MO 65270 Phone: 660-616-0022 | |
Dr. Justin Gary Lamonda, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1145 S Morley St, Moberly, MO 65270 Phone: 660-263-7062 | |
Syed Rashid, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1529 Union Ave Ste A, Moberly, MO 65270 Phone: 660-269-8550 Fax: 660-269-8555 |